AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 217 filers reported holding AMICUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,350,080 | -33.1% | 275,500 | -30.9% | 0.02% | -31.8% |
| Q2 2023 | $5,010,473 | -75.2% | 398,923 | -78.1% | 0.02% | -80.0% |
| Q1 2023 | $20,178,255 | -14.8% | 1,819,500 | -6.2% | 0.11% | -5.2% |
| Q4 2022 | $23,672,748 | -13.7% | 1,938,800 | -26.2% | 0.12% | -13.4% |
| Q3 2022 | $27,422,000 | +46.6% | 2,626,600 | +50.8% | 0.13% | +61.4% |
| Q2 2022 | $18,711,000 | +2.6% | 1,742,200 | -9.5% | 0.08% | +31.7% |
| Q1 2022 | $18,238,000 | -25.8% | 1,925,900 | -9.5% | 0.06% | +21.2% |
| Q4 2021 | $24,583,000 | +3916.8% | 2,128,400 | +3220.4% | 0.05% | +5100.0% |
| Q3 2021 | $612,000 | -72.2% | 64,100 | -71.9% | 0.00% | -80.0% |
| Q2 2021 | $2,201,000 | -88.0% | 228,300 | -87.7% | 0.01% | -88.9% |
| Q1 2021 | $18,391,000 | +288.3% | 1,861,400 | +282.8% | 0.04% | +125.0% |
| Q4 2019 | $4,736,000 | – | 486,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |